We are interested in early detection and tracking of cognitive and functional decline in the preclinical stages of Alzheimer’s disease, leveraging information that can be gathered from personal devices in the home environment including smartphone-based cognitive testing (using the Boston Remote Assessment for Neurocognitive Health-BRANCH), digital self-report of cognitive functioning, and passive monitoring.